NCT03444337 High-resolution MRI of Atrial Fibrillation Patients Prior to Focal Impulse and Rotor Modulation (FIRM) Ablation
| NCT ID | NCT03444337 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2016-11-03 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2016-11-03 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients undergoing FIRM guided ablation of atrial fibrillation will undergo high resolution MRI imaging to determine correlation of underlying anatomic fibrotic regions with FIRM targeted sites for ablation.
Eligibility Criteria
Inclusion Criteria: 1. Patients with symptomatic paroxysmal or persistent atrial fibrillation undergoing clinically-indicated ablation procedure employing FIRM mapping with pre-operative MRI. 2. Subjects must be at least 18 years of age. Exclusion Criteria: 1. LAA thrombus present on pre-procedure TEE 2. Unable to undergo MRI imaging 3. Unable to receive gadolinium contrast.
Contact & Investigator
Deanna Golden-Kreutz, RN, Phd
STUDY DIRECTOR
Ohio State University
Frequently Asked Questions
Who can join the NCT03444337 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03444337 currently recruiting?
Yes, NCT03444337 is actively recruiting participants. Contact the research team at Adrianne.Miller@osumc.edu for enrollment information.
Where is the NCT03444337 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT03444337 clinical trial?
NCT03444337 is sponsored by Ohio State University. The principal investigator is Deanna Golden-Kreutz, RN, Phd at Ohio State University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.